Skip to main content
Earnings Labs
CorMedix Inc. logo

CorMedix Inc. (CRMD)

NASDAQ·Healthcare·Biotechnology

$5.42

+1.88%

Mkt Cap $407.65M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (9 analysts)

$14.50

Range $14.00 – $15.00

Implied Upside

+167.5%

Consensus $14.50 vs current $5.42